Dicerna Pharmaceuticals Inc (DRNA)

21.23 -0.07  -0.33% NASDAQ Oct 15, 16:00 21.25 +0.02  +0.09% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All DRNA News

News

View All Events

Events

Date Type Description
11/05/2021 Earnings Results Q3 2021 Earnings Results
11/05/2021 16:30 EST Earnings Calls Q3 2021 Earnings Call
08/09/2021 Earnings Results Q2 2021 Earnings Results
08/09/2021 08:00 EST Earnings Calls Q2 2021 Earnings Call
06/03/2021 08:30 EST AGM 2020 Annual General Meeting
05/06/2021 Earnings Results Q1 2021 Earnings Results
05/06/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
02/25/2021 Earnings Results Q4 2020 Earnings Results
02/25/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, cardiovascular diseases, cancers, and other liver problems. The company uses its ribonucleic acid interference technology platform to develop its products. In addition, Dicerna’s proprietary GalXC technology focuses on silencing disease-causing genes. The product candidates are nedosiran (for primary hyperoxaluria), belcesiran (for genetic liver disease), DCR-PCSK9 (for cardiovascular disease), and RG6346 (for hepatitis B virus) among others. Dicerna generates revenue by forming collaborative relationships with pharmaceutical companies such as Eli Lilly, Roche, Novo Nordisk, and others.
  • URL: https://www.dicerna.com
  • Investor Relations URL: https://investors.dicerna.com/
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Nov. 05, 2021
  • Last Earnings Release: Aug. 09, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
PBE Invesco Dynamic Biotech & Genome ETF 2.89%
F00001553T AAM Biotechnology Opps 2020-1 F RE 2.15%
F000017IAC AAM Peroni Growth Summer 2021 F RE 2.12%
INVNX Evolutionary Tree Innovators 2.11%
GNOM Global X Genomics & Biotechnology ETF 1.61%
FNDRX FRC Founders Index 0.30%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.